Vanguard Group Inc. Purchases 255,519 Shares of CryoPort, Inc. (CYRX)

Vanguard Group Inc. raised its position in CryoPort, Inc. (NASDAQ:CYRX) by 96.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 519,100 shares of the consumer goods maker’s stock after acquiring an additional 255,519 shares during the quarter. Vanguard Group Inc. owned approximately 2.17% of CryoPort worth $2,554,000 at the end of the most recent quarter.

Separately, Northern Trust Corp lifted its holdings in CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock valued at $109,000 after acquiring an additional 11,358 shares during the period. 18.17% of the stock is owned by institutional investors.

Shares of CryoPort, Inc. (CYRX) opened at $8.10 on Thursday. CryoPort, Inc. has a 1 year low of $1.96 and a 1 year high of $10.40.

A number of research analysts have weighed in on the company. Janney Montgomery Scott increased their target price on CryoPort from $8.00 to $10.00 and gave the company a “buy” rating in a report on Wednesday, August 9th. Cowen reissued an “outperform” rating and issued a $11.00 target price (up previously from $7.50) on shares of CryoPort in a report on Tuesday, September 12th. Needham & Company LLC increased their target price on CryoPort from $8.50 to $10.00 and gave the company a “buy” rating in a report on Wednesday, August 30th. Finally, Roth Capital assumed coverage on CryoPort in a report on Thursday, November 30th. They issued a “buy” rating and a $12.50 target price on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. CryoPort currently has a consensus rating of “Buy” and a consensus target price of $33.50.

WARNING: “Vanguard Group Inc. Purchases 255,519 Shares of CryoPort, Inc. (CYRX)” was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.chaffeybreeze.com/2017/12/07/vanguard-group-inc-purchases-255519-shares-of-cryoport-inc-cyrx.html.

CryoPort Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Institutional Ownership by Quarter for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply